Literature DB >> 1930881

Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia.

M Maes1, B Minner, E Suy, C Vandervorst, J Raus.   

Abstract

In order to delineate putatively coexisting dysregulations between sympathoadrenal system and hypothalamic-pituitary-adrenal (HPA)-axis during depression, the authors measured the following: the pre and postdexamethasone (1 mg) 24 hr urine excretion of noradrenaline, dopamine, adrenaline, 3-methoxy-4-hydroxyphenylglycol (MHPG), free cortisol (UFC), and plasma cortisol. Melancholic patients were characterized by a significantly higher excretion of noradrenaline, dopamine and adrenaline, combined with significantly increased UFC, postdexamethasone plasma cortisol, and UFC values. We found significant and positive correlations between UFC on the one hand, and the 24hr urine excretion of noradrenaline, dopamine, and adrenaline, on the other. By the same token, we established significant relationships between the 24 hr urine excretion of those catecholamines and the postdexamethasone UFC and plasma cortisol values. Cortisol nonsuppressors exhibited a significantly higher excretion of noradrenaline, dopamine and adrenaline, as compared with cortisol suppressors. Dexamethasone administration did not have a significant effect on the urinary output of noradrenaline, dopamine, adrenaline or MHPG.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1930881     DOI: 10.1007/bf01244945

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  63 in total

1.  Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity.

Authors:  P E Stokes; J W Maas; J M Davis; S H Koslow; R C Casper; P M Stoll
Journal:  Am J Psychiatry       Date:  1987-07       Impact factor: 18.112

2.  Plasma norepinephrine levels are influenced by sodium intake, glucocorticoid administration, and circadian changes in normal man.

Authors:  M Stene; N Panagiotis; M L Tuck; J R Sowers; D Mayes; G Berg
Journal:  J Clin Endocrinol Metab       Date:  1980-12       Impact factor: 5.958

3.  Noradrenergic function and the cortisol response to dexamethasone in depression.

Authors:  A L Rubin; L H Price; D S Charney; G R Heninger
Journal:  Psychiatry Res       Date:  1985-05       Impact factor: 3.222

4.  Analysis of urinary 3-methoxy-4-hydroxyphenylglycol by high-performance liquid chromatography and electrochemical detection.

Authors:  P Moleman; J J Borstrok
Journal:  J Chromatogr       Date:  1982-02-12

5.  Depression: new evidence in support of biological differentiation.

Authors:  P E Garfinkel; J J Warsh; H C Stancer
Journal:  Am J Psychiatry       Date:  1979-04       Impact factor: 18.112

6.  Glucocorticoid receptors and regulation of phenylethanolamine-N-methyltransferase activity in cultured chromaffin cells.

Authors:  K L Kelner; H B Pollard
Journal:  J Neurosci       Date:  1985-08       Impact factor: 6.167

7.  Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms.

Authors:  A F Schatzberg; A J Rothschild; P J Langlais; J E Lerbinger; J J Schildkraut; J O Cole
Journal:  Psychiatry Res       Date:  1987-02       Impact factor: 3.222

8.  Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in primary unipolar major depressive disorder.

Authors:  A S de Villiers; V A Russell; M E Carstens; C Aalbers; C A Gagiano; D O Chalton; J J Taljaard
Journal:  Psychiatry Res       Date:  1987-10       Impact factor: 3.222

9.  Lack of correlation between DST results and urinary MHPG in depressed inpatients.

Authors:  H Lôo; M F Poirier; T Dennis; C Benkelfat; J M Vanelle; C Gay; A Galinowski; S Askienazy; B Scatton
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

10.  The dexamethasone suppression test, the Hamilton Depression Rating Scale and the DSM-III depression categories.

Authors:  M Maes; M De Ruyter; P Hobin; E Suy
Journal:  J Affect Disord       Date:  1986 May-Jun       Impact factor: 4.839

View more
  6 in total

Review 1.  The unknown mechanism of the overtraining syndrome: clues from depression and psychoneuroimmunology.

Authors:  Lawrence E Armstrong; Jaci L VanHeest
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

2.  Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants.

Authors:  Richard R Rubin; William C Knowler; Yong Ma; David G Marrero; Sharon L Edelstein; Elizabeth A Walker; Sanford A Garfield; Edwin B Fisher
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

3.  Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depression.

Authors:  In Kyoon Lyoo; Sujung Yoon; Alan M Jacobson; Jaeuk Hwang; Gail Musen; Jieun E Kim; Donald C Simonson; Sujin Bae; Nicolas Bolo; Dajung J Kim; Katie Weinger; Junghyun H Lee; Christopher M Ryan; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2012-12

Review 4.  Severe depression: is there a best approach?

Authors:  S B Sonawalla; M Fava
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis.

Authors:  M J Knol; J W R Twisk; A T F Beekman; R J Heine; F J Snoek; F Pouwer
Journal:  Diabetologia       Date:  2006-03-07       Impact factor: 10.122

6.  Depressive symptoms and risk of type 2 diabetes in women.

Authors:  Cassandra Arroyo; Frank B Hu; Louise M Ryan; Ichiro Kawachi; Graham A Colditz; Frank E Speizer; JoAnn Manson
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.